HENLIUS
LIVE

Serial Number

98230723

Owner

Shanghai Henlius Biotech, Inc.

Attorney

Lawrence J. Crain

Filing Date

Oct 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HENLIUS Trademark

Serial Number: 98230723

HENLIUS is a trademark filed by Shanghai Henlius Biotech, Inc. on October 19, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Shanghai Henlius Biotech, Inc. (9 trademarks)

Pilot Free Trade Zone, Pudong District
Shanghai 201210 , CN

Entity Type: 03

Trademark Details

Filing Date

October 19, 2023

Registration Date

Not Registered

Published for Opposition

October 1, 2024

Goods & Services

Medical clinic services; pharmacy advice in the nature of medication counseling; therapy services, namely, drug regimen design; rest home services; dietary and nutritional advice; beauty salon services; rental of sanitary installations; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; telemedicine services

Medicines for human purposes for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; pharmaceutical preparations for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; drugs for medical purposes in the nature of pharmaceutical preparations for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; vaccines; Capsules sold empty for medicines; biological preparations for medical purposes for the treatment of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; diagnostic preparations for medical purposes; wadding for medical purposes; chemical preparations for medical purposes, namely, for oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases

Scientific laboratory services; scientific research; Technological research in the field of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; conducting technical project studies in the field of oncology, autoimmune diseases, ophthalmic diseases, nervous system diseases, and digestive system diseases; quality control for others; medical research; research and development of new products for others; biological research; chemical research; Scientific research in the nature of conducting clinical trials for others; material testing; chemistry services in the nature of research in the field of chemistry; industrial design; design of interior decor; dress designing; software as a service (SAAS) services featuring software for development of drug research methods; computer software design; interior design

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2026 EXRA
SOU EXTENSION 3 GRANTED
May 19, 2026 EX3G
SOU EXTENSION 3 FILED
May 19, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
May 19, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 4, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 4, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 29, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 29, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 29, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2024 REAP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 27, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 5, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 26, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2023 NWOS
NEW APPLICATION ENTERED
Oct 23, 2023 NWAP